Inspira Technologies Oxy BHN Ltd IINN shares are trading higher after the company signed an agreement with Waas Group for the development 1,040 ART systems in Spain and Portugal.
"Portugal and Spain are important markets in Europe that have extensive experience operating extracorporeal technologies. We see this as an advantage in ensuring the rapid penetration and adoption of our innovative ART device by the local medical community," stated Joe Hayon, Inspira Technologies' Co-Founder, President and Chief Financial Officer.
"The WAAS Group's team has an impressive record in penetrating the local market with innovative products and leveraging them within the medical community," Hayon said.
Inspira Technologies is a specialty medical device company engaged in the research, development, manufacture and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure.
Inspira Technologies has a 52-week high of $7.89 and a 52-week low of $2.25.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
